Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06582654

Normalizing Antibody Detection in First-void Urine

Sponsor: Universiteit Antwerpen

View on ClinicalTrials.gov

Summary

The aim of this study is to develop robust analytical protocols for the monitoring of vaccine induced immunity against the Human Papillomavirus (HPV) in first-void urine samples and to examine fluctuations of urinary HPV-specific antibodies and potential normalization markers in different cohorts.

Official title: URINORM: Normalizing Antibody Detection in First-void Urine

Key Details

Gender

All

Age Range

9 Years - 70 Years

Study Type

OBSERVATIONAL

Enrollment

150

Start Date

2023-12-07

Completion Date

2026-01-01

Last Updated

2024-09-03

Healthy Volunteers

Yes

Interventions

DEVICE

Sampling

Collection of first-void urine (i.e. the initial stream of the urine) with the Colli-Pee device (Novosanis, Belgium) (6-21 samples over a period of 36 days). Collection of blood samples (2 samples, at day 1 and 36 of the study).

Locations (1)

University of Antwerp

Edegem, Antwerp, Belgium